As molecular effects of obesity are largely mediated by adipocytokine leptin, finding effective novel strategies to antagonize neoplastic effects of leptin is desirable to disrupt obesity-cancer axis. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.